ScoreWhy is Kilitch Drugs (India) Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.01 times
2
Healthy long term growth as Operating profit has grown by an annual rate 43.90%
- NET SALES(Q) At Rs 44.88 cr has Fallen at -23.8% (vs previous 4Q average)
- PAT(Q) At Rs 2.91 cr has Fallen at -61.4% (vs previous 4Q average)
- DEBT-EQUITY RATIO(HY) Highest at 0.32 times
3
With ROE of 10.8, it has a Expensive valuation with a 2.7 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 20.98%, its profits have risen by 7.3% ; the PEG ratio of the company is 24.8
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Consistent Returns over the last 3 years
- Along with generating 20.98% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Kilitch Drugs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kilitch Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Kilitch Drugs
20.98%
0.44
47.21%
Sensex
-9.29%
-0.69
13.52%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
24.93%
EBIT Growth (5y)
43.90%
EBIT to Interest (avg)
4.81
Debt to EBITDA (avg)
1.79
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0.72
Tax Ratio
25.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.12%
ROCE (avg)
10.97%
ROE (avg)
8.85%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
38
Price to Book Value
2.67
EV to EBIT
23.63
EV to EBITDA
21.11
EV to Capital Employed
2.55
EV to Sales
3.23
PEG Ratio
24.80
Dividend Yield
NA
ROCE (Latest)
11.00%
ROE (Latest)
10.79%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(Latest six months)
At Rs 134.48 cr has Grown at 28.85%
PAT(Latest six months)
At Rs 17.43 cr has Grown at 29.78%
-12What is not working for the Company
NET SALES(Q)
At Rs 44.88 cr has Fallen at -23.8% (vs previous 4Q average
PAT(Q)
At Rs 2.91 cr has Fallen at -61.4% (vs previous 4Q average
DEBT-EQUITY RATIO(HY)
Highest at 0.32 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.96 times
PBDIT(Q)
Lowest at Rs 2.93 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 6.53%
NON-OPERATING INCOME(Q)
is 75.13 % of Profit Before Tax (PBT
EPS(Q)
Lowest at Rs 0.83
Loading Valuation Snapshot...
Here's what is not working for Kilitch Drugs
Net Sales - Quarterly
At Rs 44.88 cr has Fallen at -23.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 58.87 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 2.91 cr has Fallen at -61.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 7.54 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 2.93 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 6.53%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Non Operating Income - Quarterly
is 75.13 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.83
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Highest at 0.32 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 1.96 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
